title: Advanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures.
authors.affiliation: Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. oskari.heikinheimo@helsinki.fi
authors.forename: Oskari
authors.initials: O
authors.lastname: Heikinheimo
authors.forename: Arto
authors.initials: A
authors.lastname: Leminen
authors.forename: Bruno
authors.initials: B
authors.lastname: Cacciatore
authors.forename: Eeva-Marja
authors.initials: EM
authors.lastname: Rutanen
authors.forename: Pauli
authors.initials: P
authors.lastname: Kajanoja
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000328:Adult; D002584:Cervix Uteri; D004359:Drug Therapy, Combination; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D015735:Mifepristone / Q000008:administration & dosage; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000628:therapy*
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone; D008727:Methotrexate